PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 201 filers reported holding PORTOLA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $13,000 | +225.0% | 750 | +31.6% | 0.00% | – |
Q1 2020 | $4,000 | -82.6% | 570 | -41.8% | 0.00% | – |
Q4 2019 | $23,000 | +155.6% | 980 | +206.2% | 0.00% | – |
Q3 2019 | $9,000 | 0.0% | 320 | 0.0% | 0.00% | – |
Q2 2019 | $9,000 | -18.2% | 320 | 0.0% | 0.00% | – |
Q1 2019 | $11,000 | +83.3% | 320 | 0.0% | 0.00% | – |
Q4 2018 | $6,000 | -33.3% | 320 | 0.0% | 0.00% | – |
Q3 2018 | $9,000 | -47.1% | 320 | -27.3% | 0.00% | – |
Q2 2018 | $17,000 | +54.5% | 440 | +25.7% | 0.00% | – |
Q1 2018 | $11,000 | -35.3% | 350 | 0.0% | 0.00% | – |
Q4 2017 | $17,000 | -10.5% | 350 | 0.0% | 0.00% | – |
Q3 2017 | $19,000 | -5.0% | 350 | 0.0% | 0.00% | – |
Q2 2017 | $20,000 | +100.0% | 350 | +40.0% | 0.00% | – |
Q1 2017 | $10,000 | -63.0% | 250 | -79.2% | 0.00% | – |
Q4 2016 | $27,000 | 0.0% | 1,200 | 0.0% | 0.00% | – |
Q3 2016 | $27,000 | -3.6% | 1,200 | 0.0% | 0.00% | – |
Q2 2016 | $28,000 | +75.0% | 1,200 | +50.0% | 0.00% | – |
Q1 2016 | $16,000 | – | 800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fernwood Investment Management, LLC | 232,952 | $5,498,000 | 5.39% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,673,727 | $86,700,000 | 3.41% |
Redmile Group, LLC | 1,466,537 | $34,610,000 | 3.31% |
SECTORAL ASSET MANAGEMENT INC | 1,229,382 | $29,013,000 | 3.00% |
HARVEY CAPITAL MANAGEMENT INC | 206,530 | $4,874,000 | 2.44% |
Marcus Capital, LLC | 75,150 | $1,774,000 | 1.87% |
Cormorant Asset Management, LP | 396,000 | $9,346,000 | 1.32% |
Rail-Splitter Capital Management, LLC | 221,414 | $5,225,000 | 1.25% |
Temasek Holdings (Private) Ltd | 6,583,568 | $155,372,000 | 1.21% |
EMERALD MUTUAL FUND ADVISERS TRUST | 636,526 | $15,022,000 | 0.84% |